{
    "clinical_study": {
        "@rank": "116079", 
        "arm_group": [
            {
                "arm_group_label": "T2762", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Vismed\u00ae", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "Comparison of the efficacy and safety of T2762 and Vismed\u00ae in the treatment of moderate to\n      severe Dry Eye Syndrome"
        }, 
        "brief_title": "Efficacy and Safety of T2762 and Vismed\u00ae in Dry Eye Syndrome", 
        "condition": "Dry Eye Syndrome", 
        "condition_browse": {
            "mesh_term": [
                "Dry Eye Syndromes", 
                "Keratoconjunctivitis Sicca"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Signed and dated informed consent\n\n          -  Male or female aged from \u2265 18 years old.\n\n          -  Known Dry Eye Syndrome requiring artificial tears within the last 3 months prior to\n             study selection.\n\n        Exclusion Criteria:\n\n          -  Best far corrected visual acuity < 1/10\n\n          -  Severe blepharitis\n\n          -  Severe Dry Eye"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "76", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02023268", 
            "org_study_id": "LT2762-PIII-08/13", 
            "secondary_id": "2013-A01292-43"
        }, 
        "intervention": [
            {
                "arm_group_label": "T2762", 
                "description": "1 drop in each eye 3 to 6 times daily during 84 days", 
                "intervention_name": "T2762", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Vismed\u00ae", 
                "description": "1 drop in each eye 3 to 6 times daily during 84 days", 
                "intervention_name": "Vismed\u00ae", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 13, 2014", 
        "location": {
            "contact": {
                "email": "l.delval@laboratoires-thea.fr", 
                "last_name": "Laurent Delval, MD", 
                "phone": "04-73-98-14-25"
            }, 
            "facility": {
                "address": {
                    "city": "Clermont-Ferrand", 
                    "country": "France"
                }
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Phase III: Comparison of the Efficacy and Safety of T2762 and Vismed\u00ae in the Treatment of Moderate to Severe Dry Eye Syndrome", 
        "overall_contact": {
            "email": "l.delval@laboratoires-thea.fr", 
            "last_name": "Laurent Delval, MD", 
            "phone": "04-73-98-14-25"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
                "France: Committee for the Protection of Personnes"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Global ocular staining", 
            "safety_issue": "No", 
            "time_frame": "Day 35"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02023268"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Laboratoires Thea", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Laboratoires Thea", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}